VanEck Associates
ADNT icon

VanEck Associates’s Adient ADNT Stock Holding History

VanEck Associates’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,851
Closed -$1.41M – 1364
2023
Q4 		$1.41M Sell
38,851
-28,116
-42% -$965K ﹤0.01% 898
2023
Q3 		$2.46M Buy
66,967
+38,604
+136% +$1.54M 0.01% 706
2023
Q2 		$1.09M Buy
28,363
+12,627
+80% +$467K ﹤0.01% 847
2023
Q1 		$645K Buy
15,736
+2,721
+21% +$114K ﹤0.01% 950
2022
Q4 		$451K Buy
+13,015
New +$455K ﹤0.01% 944

Other funds holding ADNT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VanEck Associates's ADNT Position: Q1 2024 in Review

VanEck Associates sold out of Adient (ADNT) in Q1 2024, closing a stake of 38,851 shares — an estimated $1.41M sold.

VanEck Associates first reported a position in ADNT in Q4 2022 and held it in 5 quarters. The position peaked at $2.46M in Q3 2023. 311 funds tracked by Wall St. Rank hold ADNT as of Q1 2024.

  • VanEck Associates reported no remaining Adient position as of Q1 2024 after selling out during the quarter.
  • VanEck Associates sold 38,851 Adient shares in Q1 2024, an estimated $1.41M.
  • VanEck Associates first reported a position in Adient in Q4 2022 and held it in 5 quarters.
  • VanEck Associates's Adient position peaked at $2.46M in Q3 2023.
  • 311 funds tracked by Wall St. Rank held Adient as of Q1 2024.

Based on VanEck Associates's 13F filing for Q1 2024, filed 30 Apr 2024.